Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19:Study
PTI, Aug 2, 2021, 4:46 PM IST
Hyderabad: Bharat Biotech’s COVID-19 vaccine Covaxin (BBV152) is effective against the Delta Plus (AY.1) variant of the coronavirus, according to a study published in biorxivby the Indian Council of Medical and Research (ICMR).
”Here, we have evaluated the IgG antibody titer and neutralizing potential of sera of COVID-19 naive individuals full doses of BBV152 vaccine, COVID-19 recovered cases with full dose vaccines and breakthrough cases post-immunization BBV152 vaccines against Delta, Delta AY.1 and B.1.617.3.,” the study said.
The recent emergence of the SARS-CoV-2 Variant B.1.617.2 (Delta) variant with its high transmissibility has led to the second wave in India.
Covaxin, a whole-virion inactivated SARS-CoV-2 vaccine used for mass immunization in the country, showed a 65.2 percent protection against the Delta variant in a double-blind, randomized, multicentre, phase 3 clinical trial.
Subsequently, Delta has further mutated to Delta AY.1, AY.2, and AY.3.
Of these, AY.1 variant was first detected in India in April 2021 and subsequently from 20 other countries as well, the study said.
The study is a pre-print and has not been peer-reviewed.
Covaxin demonstrated 77.8 percent effectiveness against symptomatic COVID-19 and 65.2 percent protection against the B.1.617.2 Delta variant, Bharat Biotech had said while concluding the final analysis of Covaxin efficacy from Phase3 trials on July 3.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
Low back pain, depression, headaches main causes of poor health: Study
Surgical options for Parkinson’s disease
MUST WATCH
Latest Additions
Lok Sabha Polls 2024: Congress suspends Surat candidate Kumbhani, whose nomination form was rejected
Sibal criticizes EC for not issuing notice to Modi, terms it ‘powerless entity’
Yuvraj identifies Surya, Bumrah as key to India’s prospects in T20 World Cup
SC verdict on EVM a vindication of our faith in institutions: PM Modi in Bihar rallies
Karnataka: 50% Voter Turnout Achieved in 14 Lok Sabha Constituencies